03.26.15
NinePoint Medical Inc. has a new leader.
The company has appointed Christopher von Jako, Ph.D., as president/CEO. von Jako brings to NinePoint Medical more than 20 years of experience in the global medical device industry and has demonstrated success leading and growing the value of organizations with early-stage commercial products.
“Chris is a passionate and technology-minded individual who deeply understands the dynamics of today’s medical device field,” said Tom Miller, NinePoint’s board chairman. “We believe his commercial insights and leadership experience will be incredibly valuable to NinePoint as we continue to expand the reach of our NvisionVLE Imaging System and plan for future growth.”
von Jako joins NinePoint Medical from NeuroTherm Inc., a medical device company focused on minimally invasive solutions for pain management, where he served as president/CEO. NeuroTherm was divested to St. Jude Medical Inc. in August last year for $200 million. Prior to NeuroTherm, he was president of ActiViews Inc., which developed and manufactured minimally invasive navigation solutions for image-guided procedures. Earlier in his career, von Jako served in senior executive roles of progressive responsibility with Integra LifeSciences Corporation, Covidien plc, Medtronic Inc., and Radionics.
von Jako earned a double B.S. from Bates College (Lewiston, Me.), a M.S. from the Massachusetts Institute of Technology, and a Ph.D. from the University of Pécs Medical School (Hungary).
“NinePoint Medical has built strong momentum around their NvisionVLE Imaging System, which has been adopted by many of the leading hospitals in the U.S. and recently surpassed a milestone of 1,000 procedures completed since launch,” said von Jako. “I am very excited about the promise of this technology and the expertise of the management team, and look forward to working together.”
NinePoint Medical’s proprietary NvisionVLE Imaging System enables physicians to endoscopically view real-time, high-resolution, volumetric images of organs and tissues up to 3 millimeters deep at seven micron resolution. Utilizing an advanced form of Fourier-domain optical coherence tomography, NvisionVLE provides physicians and pathologists with cross-sectional, volumetric digital images of the esophagus – including below the surface of the tissue. This imaging information can be used to aid clinical decision-making relative to biopsy placement or treatment planning. The NvisionVLE Imaging System is indicated for use as an imaging tool in the evaluation of human tissue microstructure, including esophageal tissue microstructure, by providing two-dimensional, cross-sectional, real-time depth visualization.
Developed at the Wellman Center for Photomedicine at Massachusetts General Hospital, this advanced OCT technology was licensed by NinePoint Medical in 2010 as part of the largest intellectual property agreement for medical device technology in the hospital’s history.
NinePoint Medical develops real-time imaging devices designed to improve patient care. Headquartered in Cambridge, Mass., NinePoint Medical is backed by Third Rock Ventures, Prospect Venture Partners and Corning Inc.
The company has appointed Christopher von Jako, Ph.D., as president/CEO. von Jako brings to NinePoint Medical more than 20 years of experience in the global medical device industry and has demonstrated success leading and growing the value of organizations with early-stage commercial products.
“Chris is a passionate and technology-minded individual who deeply understands the dynamics of today’s medical device field,” said Tom Miller, NinePoint’s board chairman. “We believe his commercial insights and leadership experience will be incredibly valuable to NinePoint as we continue to expand the reach of our NvisionVLE Imaging System and plan for future growth.”
von Jako joins NinePoint Medical from NeuroTherm Inc., a medical device company focused on minimally invasive solutions for pain management, where he served as president/CEO. NeuroTherm was divested to St. Jude Medical Inc. in August last year for $200 million. Prior to NeuroTherm, he was president of ActiViews Inc., which developed and manufactured minimally invasive navigation solutions for image-guided procedures. Earlier in his career, von Jako served in senior executive roles of progressive responsibility with Integra LifeSciences Corporation, Covidien plc, Medtronic Inc., and Radionics.
von Jako earned a double B.S. from Bates College (Lewiston, Me.), a M.S. from the Massachusetts Institute of Technology, and a Ph.D. from the University of Pécs Medical School (Hungary).
“NinePoint Medical has built strong momentum around their NvisionVLE Imaging System, which has been adopted by many of the leading hospitals in the U.S. and recently surpassed a milestone of 1,000 procedures completed since launch,” said von Jako. “I am very excited about the promise of this technology and the expertise of the management team, and look forward to working together.”
NinePoint Medical’s proprietary NvisionVLE Imaging System enables physicians to endoscopically view real-time, high-resolution, volumetric images of organs and tissues up to 3 millimeters deep at seven micron resolution. Utilizing an advanced form of Fourier-domain optical coherence tomography, NvisionVLE provides physicians and pathologists with cross-sectional, volumetric digital images of the esophagus – including below the surface of the tissue. This imaging information can be used to aid clinical decision-making relative to biopsy placement or treatment planning. The NvisionVLE Imaging System is indicated for use as an imaging tool in the evaluation of human tissue microstructure, including esophageal tissue microstructure, by providing two-dimensional, cross-sectional, real-time depth visualization.
Developed at the Wellman Center for Photomedicine at Massachusetts General Hospital, this advanced OCT technology was licensed by NinePoint Medical in 2010 as part of the largest intellectual property agreement for medical device technology in the hospital’s history.
NinePoint Medical develops real-time imaging devices designed to improve patient care. Headquartered in Cambridge, Mass., NinePoint Medical is backed by Third Rock Ventures, Prospect Venture Partners and Corning Inc.